EGFR signaling promotes resistance to CHK1 inhibitor prexasertib in triple negative breast cancerKevin J. Lee, Natalie R. Gassman, Michele A. Schuler et al.|Cancer Drug Resistance|2021Cited by 11
Abstract 3464: Vitamin D supplementation to improve doxorubicin-induced cardiotoxicity in triple negative breast cancersKevin J. Lee, Natalie R. Gassman, Griffin Wright et al.|Cancer Research|2020Cited by 0